KEVIN RAKIN
CIK 1184421 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.60M
Companies
6
Total Filings
49
Lifetime Open-Market Net
$74.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELUT | Director | 518,539 | $0.92 | $474.5K | $296.8K | 6 | 2026-06-15 |
| QSI | Director | 1,220,512 | $0.76 | $928.3K | -$191.2K | 8 | 2026-05-20 |
| ORMP | Director | 46,661 | $4.17 | $194.6K | -$536.9K | 17 | 2022-03-22 |
| ELUTIA INC. (AZYO) Delisted | Director | 4,062,451 | $1.49 | $6.05M | $75.00M | 1 | 2020-10-13 |
| Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Director | 6,000 | — | — | $27.3K | 4 | 2008-09-05 |
| VION PHARMACEUTICALS INC (VION) Delisted | Director | 6,100 | — | — | $23.9K | 3 | 2007-06-28 |
Recent Filings · Page 2 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-22 | QSI | Other (J) | −601,000 | $0 | EDGAR |
| 2022-12-16 | QSI | Sell (S) | −89,000 | -$191.2K | EDGAR |
| 2022-05-13 | QSI | Grant (A) | — | $0 | EDGAR |
| 2022-03-22 | ORMP | Sell (S) | −10,000 | -$94.1K | EDGAR |
| 2022-02-22 | ORMP | Mixed | +3,657 | $5 | EDGAR |
| 2022-02-15 | ORMP | Gift (G) | −5,000 | $0 | EDGAR |
| 2022-02-14 | ORMP | Gift (G) | −5,000 | $0 | EDGAR |
| 2022-01-05 | ORMP | Grant (A) | +6,000 | $0 | EDGAR |
| 2021-12-17 | ORMP | Gift (G) | −5,000 | $0 | EDGAR |
| 2021-09-20 | ORMP | Sell (S) | −21,100 | -$442.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.